Craft

Universe Pharmaceuticals

Stock Price

$0.3

2024-10-29

Market Capitalization

$7.4 M

2024-10-29

Revenue

$17.9 M

FY, 2025

Universe Pharmaceuticals Summary

Company Summary

Overview
Universe Pharmaceuticals is a company specializing in the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivatives (TCMDs) products. It focuses on the production of chronic condition treatments and cold and flu medicines. The company also sells biomedical drugs, medical instruments, traditional Chinese medicine pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies.
Type
Public
Status
Active
Founded
2019
HQ
Ji'an, CN | view all locations
Website
http://www.dzrzy.com/
Cybersecurity rating
Sectors

Key People

  • Gang Lai, Chairman of the Board of Directors and Chief Executive Officer

    • Lin Yang, Chief Financial Officer and Director

      • Jiawen Pang, Independent Director

        • David Sherman, Independent Director

          Operating MetricsView all

          Units Sold

          24.4M
          4.3%

          FY, 2020

          Suppliers

          728
          12.0%

          FY, 2020

          Product Categories

          2

          FY, 2020

          LocationsView all

          1 location detected

          • Ji'an, Jiangxi HQ

            China

            265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone, Ji’an, Jiangxi Province

          Universe Pharmaceuticals Financials

          Summary Financials

          Revenue (FY, 2025)
          $17.9M
          Gross profit (FY, 2025)
          $6.8M
          Net income (FY, 2025)
          ($3.7M)
          Cash (FY, 2025)
          $33.6M
          EBIT (FY, 2025)
          ($3.0M)
          Enterprise value
          ($17.0M)

          Footer menu